Chief of Staff to CEO of BridgeBio and GondolaBio

Mavericks Wanted

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement…read on

In 2015, we pioneered a “Moneyball for biotech” approach, pooling projects and promising early-stage research from academia under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare diseases and develop life-changing medicines for patients with unmet needs as fast as humanly possible. 

Together we define white space, push boundaries and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma.

BridgeBio is a commercial stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with three approved drugs and three additional positive Phase 3 results, making the company one of the most productive R&D engines in the industry’s history.

To learn more about our story and company culture, visit us at https://bridgebio.com

GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. A sister company of BridgeBio, GondolaBio secured $300M in private financing from external investors in August 2024. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas in monogenic rare diseases. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation.

What You'll Do

The Chief of Staff reports directly to the CEO of BridgeBio and GondolaBio. The primary objective of this role is to increase the leverage of the CEO, facilitate interactions and information flow across the executive leadership team, take on key cross-functional strategic initiatives, and serve as a strategic thought partner to the CEO, helping to manage and direct strategic decisions for the firm going forward.

As an extension of the CEO, this role is inherently flexible, taking a central role in projects that are of top priority for BridgeBio and GondolaBio. The person in this role will help determine the theory of how we want to manage the firm going forward. The person will have a demonstrated ability to make connections, manage conversations and negotiations with potential partners, interface with investors, and coordinate with Affiliate companies with a high degree of emotional intelligence. The person will ideate and manage strategic initiatives, organize, and interpret incoming data, evaluate, and review ongoing programs, articulate, and define strategy. The person in this role will have significant impact on BridgeBio/GondolaBio and our ability to serve patients.

The Chief of Staff should be:

• Patient-focused
• A clear and structured communicator who distills complexity into concise insights and recommendations
• Comfortable operating in ambiguity and able to create clarity where none exists
• Influential without formal authority, able to align senior stakeholders and drive follow-through
• Detail-oriented but never lose sight of enterprise-level priorities
• Biased toward action, with a strong sense of ownership and accountability
• Resilient and adaptable, able to shift gears quickly as priorities evolve

Responsibilities

• Ensure cross-functional alignment and harmonization of strategy with operational activities across commercial launches, clinical programs, and new R&D
• Organize and interpret incoming data and discuss findings of relevant strategic analyses with senior leadership and relevant external stakeholders
• Help define / lead strategic initiatives (e.g., evaluate new scientific and information technologies, incubate new Affiliates or other ventures, and reduce rate-limiting steps in clinical development)
• Conduct weekly reviews of literature associated with ongoing and new programs of interest
• Manage key meetings with Board members and other senior leaders across BridgeBio, sometimes serving as a proxy/delegate for the CEO
• Question assumptions and challenge how things are done across BridgeBio in the service of the patient mission
• Respond to urgent issues and help coordinate cross-functional efforts
• Perform other strategic analyses and projects as needed
• Manage the operating rhythm of the Office of the CEO
• Ensure that participants are prepared prior to meetings with CEO
• Support in the representation of BridgeBio to external parties including patients, physicians, investors, media, partners, vendors, candidates, etc.

Where You'll Work

• In-person work is a requirement for 5-6 days per week. The role is primarily based out of our office in Palo Alto, CA with 1-2 days per week in our San Francisco, CA office
• Domestic and international travel is expected when required

Who You Are

• Passion for delivering life-changing treatment options into the hands of patients
• Familiarity with the drug discovery & development process
• Proven scientific and business acumen
• Demonstrated communication skills
• Demonstrated ability to solve problems using a structured, analytical approach
• Ability to handle multiple projects simultaneously
• Comfort working independently and as part of a diverse team
• Exceptional written communication and presentation skills
• Comfort with ambiguity and a self-starter attitude
• Extremely fast learner
• Exquisitely detail-oriented
• Highly empathetic and emotionally intelligent
• 3 to 6+ years of relevant business development / operations / strategy experience in biopharma
• 2 to 3 years of experience in a top-tier professional services firm (e.g., consulting or banking) strongly preferred
• PhD, MD, MBA with a biopharmaceutical focus, or other graduate degrees in the life sciences strongly preferred

Rewarding Those Who Make the Mission Possible

We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return. 

Financial Benefits:

• Market leading compensation 
• 401K with 100% employer match on first 3% & 50% on the next 2%
• Employee stock purchase program
• Pre-tax commuter benefits
• Referral program with $2,500 award for hired referrals

Health & Wellbeing:

• Comprehensive health care with 100% premiums covered - no cost to you and dependents
• Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)
• Hybrid work model - employees have the autonomy in where and how they do their work 
• Unlimited flexible paid time off - take the time that you need
• Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents
• Flex spending accounts & company-provided group term life & disability 
• Subsidized lunch via Forkable on days worked from our office

Skill Development & Career Paths:

• People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility
• We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching
• We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities